Limited Competition: Specific Pathogen Free Macaque Colonies (U42 Clinical Trial Not Allowed)

The summary for the Limited Competition: Specific Pathogen Free Macaque Colonies (U42 Clinical Trial Not Allowed) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.

Limited Competition: Specific Pathogen Free Macaque Colonies (U42 Clinical Trial Not Allowed): The purpose of this Funding Opportunity Announcement is to provide continuing support for specific pathogen free (SPF) macaque colonies previously funded under the auspices of PAR-14-066. Breeding colonies are essential to sustain Human Immunodeficiency Virus (HIV)/Acquired Immunodeficiency Syndrome (AIDS) research. Pedigree SPF macaques are free of certain viruses, which can confound the results of AIDS-related investigations or present a risk to the personnel who care for the animals. The SPF macaques are genetically characterized for major histocompatibility (MHC) class I types as defined MHC classes are critical in determining immune responses to HIV/AIDS infections.

Federal Grant Title:	Limited Competition: Specific Pathogen Free Macaque Colonies (U42 Clinical Trial Not Allowed)
Federal Agency Name:	National Institutes of Health (HHS-NIH11)
Grant Categories:	Health
Type of Opportunity:	Discretionary
Funding Opportunity Number:	PAR-18-669
Type of Funding:	Cooperative Agreement
CFDA Numbers:	93.351
CFDA Descriptions:	Information not provided
Current Application Deadline:	January 7th, 2021
Original Application Deadline:	January 7th, 2021
Posted Date:	February 21st, 2018
Creation Date:	February 21st, 2018
Archive Date:	February 12th, 2021
Total Program Funding:
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching:	No
Last Updated:	February 21st, 2018

Applicants Eligible for this Grant: Public and State controlled institutions of higher education
Additional Information on Eligibility: Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed. See FOA for full eligibility details
Link to Full Grant Announcement: http://grants.nih.gov/grants/guide/pa-files/PAR-18-669.html
Grant Announcement Contact: NIH OER Webmaster
[email protected]

If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
Similar Government Grants: • Utilizing Equipment to Study Environmental Extrinsic Factors and Enhance Rigor and Reprodu...; • Limited Competition: Mutant Mouse Resource and Research Centers (U42 Clinical Trial Not Al...; • Modern Equipment for Shared-use Biomedical Research Facilities: Advancing Research-Related...; • Limited Competition: National Primate Research Centers (P51) (Clinical Trials Not Allowed); • Limited Competition: Small Grant Program for ORIP Special Emphasis Research Career Award (...; • Development of novel and emerging technologies for the accurate detection and diagnosis of...; • Development of Novel and Emerging Technologies for the Accurate Detection and Diagnosis of...; • Shared Instrumentation Grant Program (S10)
More Grants from the National Institutes of Health: • Using Neuromodulation to Characterize the Continuum of Pathophysiology Between Substance U...; • NIDCR Predoctoral to Postdoctoral Transition Award to Promote a Diverse Dental, Oral and C...; • Neuropathological Interactions Between COVID-19 and ADRD (R01 - Clinical Trial Not Allowed...; • Promoting Broad Participation in NIDCD's Extramural Workforce through Research Education E...; • Protective Strategies to Reduce Amyloid Related Imaging Abnormalities (ARIA) After Anti-Am...